Invention Grant
- Patent Title: Compounds for the prevention and treatment of cardiovascular diseases
-
Application No.: US15710200Application Date: 2017-09-20
-
Publication No.: US10532054B2Publication Date: 2020-01-14
- Inventor: Henrik C. Hansen
- Applicant: Resverlogix Corp.
- Applicant Address: CA Calgary, Alberta
- Assignee: Resverlogix Corp.
- Current Assignee: Resverlogix Corp.
- Current Assignee Address: CA Calgary, Alberta
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/517 ; A61K31/4375 ; A61K31/472 ; A61K31/496 ; A61K31/519 ; A61K31/5377 ; C07D217/24 ; C07D239/91 ; C07D279/02 ; C07D401/04 ; C07D405/04 ; A61K31/44 ; A61K31/47 ; A61K31/497 ; A61K31/535 ; A61K31/54 ; C07D471/04 ; C07F7/18 ; A61K31/695 ; A61L29/16 ; A61L31/16
Abstract:
The present disclosure relates to compounds, which are useful for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
Public/Granted literature
- US20180104245A1 COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES Public/Granted day:2018-04-19
Information query
